Zealand Pharma A/s Stock
€39.76
Your prediction
Zealand Pharma A/s Stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
Cons
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | 4.780% | -0.401% | 16.291% | -30.074% | -37.856% | 38.633% | 45.004% |
| Saniona AB | -1.740% | 9.226% | 5.308% | 194.188% | -23.462% | 143.449% | -32.815% |
| Ocuphire Pharma Inc. | 0.940% | 9.001% | 4.739% | 428.708% | 162.782% | -0.226% | - |
| Immunic Inc. | 5.880% | 2.808% | -4.562% | 24.848% | 138.372% | -19.228% | -91.904% |
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big


